• Study on the Effectiveness and Safety of Reparixin for Adults with Acute Respiratory Distress Syndrome

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy
  • Study on the Safety and Tolerance of Durvalumab and Radiotherapy for Patients with Untreated Head and Neck Squamous Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France
  • Study on Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD

    Not recruiting

    1 1
    Investigated Drugs:
    Poland Spain
  • Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Greece Poland Spain
  • Study on the Safety and Effects of Trastuzumab Deruxtecan with Drug Combination for Patients with Metastatic HER2-low Breast Cancer

    Not recruiting

    1 1 1 1
    Belgium
  • Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Italy Norway Poland Spain
  • Study on Long-Term Safety and Effectiveness of Liposomal Ciclosporin A for Patients with Bronchiolitis Obliterans Syndrome After Lung Transplantation

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark France Germany Spain
  • Study of Trastuzumab Deruxtecan Treatment for Patients with Advanced Solid Tumors Having HER2 Mutations

    Not recruiting

    2 1 1
    Investigated Drugs:
    Denmark France
  • Study on the Safety and Effectiveness of Terbinafine for Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

powered by